Lupin’s arm to acquire 100% stake in Southern Cross Pharma Pty

30 Jul 2021 Evaluate

Lupin’s wholly-owned subsidiary -- Generic Health has entered into a definitive agreement under which Lupin will acquire 100% of the shares of Southern Cross Pharma Pty (SCP).  As a part of the transaction, Generic Health will gain access to over 60 registered products having sales of over Australian dollar 30 million (approximately $22 million). This will significantly increase Lupin’s value proposition and market share in the Australian market.

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India.

Lupin Share Price

2151.05 19.25 (0.90%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1218.40
Cipla 1323.95
Zydus Lifesciences 885.20
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×